GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Common Stock

PharmaRoth Labs (PharmaRoth Labs) Common Stock : $0.14 Mil (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Common Stock?

PharmaRoth Labs's quarterly common stock stayed the same from Sep. 2010 ($0.13 Mil) to Dec. 2010 ($0.13 Mil) but then increased from Dec. 2010 ($0.13 Mil) to Mar. 2011 ($0.14 Mil).

PharmaRoth Labs's annual common stock increased from Jun. 2008 ($0.01 Mil) to Jun. 2009 ($0.13 Mil) but then stayed the same from Jun. 2009 ($0.13 Mil) to Jun. 2010 ($0.13 Mil).


PharmaRoth Labs Common Stock Historical Data

The historical data trend for PharmaRoth Labs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Common Stock Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Common Stock
0.01 0.13 0.13

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.13 0.13 0.13 0.14

PharmaRoth Labs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines